NK Endowment, NK Subsidiary, Signs Medical Device Supply Contract with Seogwipo Medical Center

NK Endowment, a deep-tech subsidiary of the KOSPI-listed company NK specializing in medical and defense technologies, announced on July 8 that it has secured an order for a multi-person hyperbaric oxygen therapy chamber (HBOT) with a capacity for 12 people and a pressure rating of 6.5 bar(g) to be supplied to the emergency medicine department of Seogwipo Medical Center in Jeju.

Photo of the exterior of a multi-person hyperbaric oxygen therapy chamber. NK Endowment.

This order represents NK Endowment’s achievement in supplying to a public healthcare institution after obtaining certification for compliance with Korea Good Manufacturing Practice (KGMP) for medical device manufacturing and quality management standards from the Korea Testing & Research Institute (KTR).

The 12-person multi-user hyperbaric oxygen therapy chamber to be supplied this time is designed to treat multiple patients simultaneously, thereby enhancing responsiveness in emergency medical settings. The company emphasized that, given the active marine and diving activities characteristic of the Jeju region, the importance of hyperbaric oxygen therapy infrastructure is extremely high, and the introduction of this equipment is expected to significantly strengthen emergency and public healthcare capabilities in southern Jeju.

The company applied a system based on the global pressure vessel certification 'ASME STAMP' from design to production, increasing structural reliability. In addition, by incorporating a control system and treatment tables optimized for medical settings, NK Endowment plans to provide a stable treatment environment for both patients and medical staff.

A representative from NK Endowment stated, "Following the acquisition of KGMP certification, which established our reliability as a medical device manufacturer, this order from Seogwipo Medical Center has enabled us to demonstrate our unrivaled technological capabilities in an actual medical environment. Since hyperbaric oxygen therapy chambers are highly complex systems where pressure control and structural safety are fundamental, we will leverage the group’s advanced high-pressure safety deep-tech expertise to further differentiate our position in the market."

Meanwhile, NK Endowment plans to actively expand the supply of multi-person hyperbaric oxygen therapy chambers, focusing on domestic public healthcare institutions and regional emergency medical centers. Furthermore, the company aims to go beyond being a simple chamber manufacturer and evolve into a next-generation 'medical high-pressure platform' enterprise that integrates high-pressure safety technology with medical devices, targeting the global market as well.

This content was produced with the assistance of AI translation services.